力诺药包：关于“力诺转债”恢复转股的提示性公告

Core Viewpoint - The company Lino Pharmaceutical announced that the "Lino Convertible Bond" will resume conversion into shares starting from September 19, 2025, following the end of the repurchase application period [2] Group 1 - The announcement was made on the evening of September 18 [2] - The resumption of conversion is significant for investors holding the convertible bonds [2]